NEW USE OF LOW-DOSE ASPIRIN AND RISK OF UPPER AND LOWER GASTROINTESTINAL BLEEDING: ASSOCIATIONS BY CASE-FATALITY, HOSPITALISATION STATUS, BLEEDING LOCATION, ASPIRIN DOSE AND DURATION IN A LARGE OBSERVATIONAL STUDY IN THE UNITED KINGDOM

(1) Complutense University of Madrid,Madrid,Spain

(2) Bayer AG,Berlin,Germany

(3) University of Zaragoza,Zaragoza,Spain

(4) Spanish Centre for Pharmacoepidemiologic Research,Madrid,Spain



This item was part of UEG Week 2017

This item can be cited as: United European Gastroenterology Journal 2017; 5 (Supplement 1)